NurExone Biologic Inc. (NRX : TSX-V)
Common Stock
$0.69
CAD
+0.05 (7.81%)
Last updated: 2026-09-08
Get NRX alerts:
NRX
NurExone Biologic Inc.
WealthAwesomePerformance
1 Day
+7.81%
1 Week
+21.05%
1 Month
+39.39%
YTD
+6.15%
Key Statistics
Market Cap
$58.91M
52W High
$1.14
52W Low
$0.43
P/E Ratio
-
50 Day MA
$0.53
200 Day MA
$0.61
Beta
0.45
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/8/2026 | $0.65 | $0.70 | $0.61 | $0.69 | $0.69 | 53,182 |
| 9/4/2026 | $0.64 | $0.64 | $0.64 | $0.64 | $0.64 | 3,500 |
| 9/3/2026 | $0.56 | $0.62 | $0.55 | $0.62 | $0.62 | 21,740 |
| 9/2/2026 | $0.59 | $0.59 | $0.57 | $0.59 | $0.59 | 27,600 |
| 9/1/2026 | $0.64 | $0.70 | $0.57 | $0.57 | $0.57 | 83,000 |
| 8/31/2026 | $0.53 | $0.55 | $0.53 | $0.55 | $0.55 | 10,000 |
| 8/28/2026 | $0.49 | $0.54 | $0.49 | $0.54 | $0.54 | 6,500 |
| 8/27/2026 | $0.53 | $0.53 | $0.49 | $0.49 | $0.49 | 53,001 |
| 8/26/2026 | $0.53 | $0.53 | $0.49 | $0.50 | $0.50 | 18,700 |
| 8/25/2026 | $0.57 | $0.57 | $0.50 | $0.52 | $0.52 | 22,300 |
Analyst Price Targets
Based on analyst covering NRX
Wall Street analysts forecast NRX stock price to rise 261.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.49
+261.1% Upside
Current Price
C$0.69
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NRX's historical volatility
30-Day Vol
108.1%
Annualized
90-Day Vol
79.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.82
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.73 | C$0.50 – C$1.06 |
| 60 trading days | C$0.78 | C$0.46 – C$1.32 |
| 90 trading days | C$0.82 | C$0.43 – C$1.57 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About NurExone Biologic Inc.
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-6.05M
- Profit Margin
- 0.00%
- ROE (TTM)
- -450.96%
- EPS (Diluted)
- -0.10
- Book Value
- 0.02
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NRX
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| CES-P | Celestial Acquisition Corp. | $0.20 | +185.71% |
| DDD | Metavista3D Inc. | $0.36 | +78.05% |
| SHRX | Sharp Therapeutics Corp. | $1.37 | +50.55% |
| SRA | Stria Lithium Inc | $1.15 | +47.44% |
| ATR-P | Aster Acquisition Corp. | $0.10 | +46.15% |
| RKV | Rakovina Therapeutics Inc | $0.32 | +45.45% |
| AAAJ-P | AAJ Capital 3 Corp. | $0.04 | +40.00% |
| FRNT | FRNT Financial Inc | $0.06 | +37.50% |
NRX.V news timeline
5 articles covering NRX.V, most recent first
Latest